DPHAY News and Press, Dechra Pharms Plc Adr From 09/08/20

U.K.-listed animal medicine maker Dechra ([[DPHAY]], [[DCHPF]]) published its annual report . The results were decent, but the strong share price run-up emphasises that the shares are not valued on fundamentals. I continue to think that the company is highly overvalued and is a definite sell....

Dechra ([[DPHAY]], [[DCHPF]]) is a U.K.-based animal medicines group. Manufacturing across seven sites including the U.K., Belgium and the U.S., they have a wide international sales reach with sales and marketing teams in 25 countries and 68 countries in which their products are sold via distr...

SAN FRANCISCO , April 15, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it has completed the sale of Mirataz ® to Dechra Pharmaceuticals PLC (LSE: DPH) for an upf...

SAN FRANCISCO , March 16, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it has entered into a transaction for the sale of Mirataz ® to Dechra Pharmaceuticals...